alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
EXHIBIT 31.2

                                CERTIFICATION

I, W. Douglas Caudell certify that:

1. I have reviewed this quarterly report on Form 10-QSB of YoCream
International, Inc. (the registrant);

2. Based on my knowledge, this report does not contain any untrue statement of
a material fact or omit to state a material fact necessary to make the
statements made, in light of the circumstances under which such statements were
made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial
information included in this report, fairly present in all material respects
the financial condition, results of operations and cash flows of the registrant
as of, and for, the periods presented in this report;

4. The registrants other certifying officer and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-15(e) and 15d-15(e)) and have:

a) Designed such disclosure controls and procedures to ensure that material
information relating to the registrant, including its consolidated
subsidiaries, is made known to us by others within those entities, particularly
during the period in which this annual report is being prepared;

b) Evaluated the effectiveness of the registrants disclosure controls and
procedures and presented in this report our conclusions about the effectiveness
of the disclosure controls and procedures, as of the end of the period covered
by this report based on such evaluation; and

c) Disclosed in this report any change in the registrants internal control over
financial reporting that occurred during the registrants most recent fiscal
quarter (registrants fourth quarter in the case of an annual report) that has
materially affected, or is reasonably likely to materially affect, the
registrants internal control over financial reporting; and

5. The registrants other certifying officer and I have disclosed, based on our
most recent evaluation of internal control over financial reporting, to the
registrants auditors and the audit committee of registrants board of directors
(or persons performing the equivalent function):

a) All significant deficiencies in the design or operation of internal controls
over financial reporting which are reasonably likely to adversely affect the
registrants ability to record, process, summarize and report financial
information; and

b) Any fraud, whether or not material, that involves management or other
employees who have a significant role in the registrants internal controls over
financial
reporting.


/s/ W. Douglas Caudell                               Dated:  June 14, 2004
----------------------
W. Douglas Caudell, Chief Financial Officer
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
       
<S>                                        <C>
<PERIOD-TYPE>                                    9-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-START>                             JAN-01-1997
<PERIOD-END>                               SEP-30-1997
<CASH>                                         489,312
<SECURITIES>                                         0
<RECEIVABLES>                                1,450,884
<ALLOWANCES>                                 (177,587)
<INVENTORY>                                          0
<CURRENT-ASSETS>                                     0
<PP&E>                                     103,288,077
<DEPRECIATION>                            (53,571,517)
<TOTAL-ASSETS>                             100,372,974
<CURRENT-LIABILITIES>                        4,145,632
<BONDS>                                     54,108,713
<COMMON>                                             0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<OTHER-SE>                                  42,118,629
<TOTAL-LIABILITY-AND-EQUITY>               100,372,974
<SALES>                                              0
<TOTAL-REVENUES>                            30,635,555
<CGS>                                                0
<TOTAL-COSTS>                               30,774,097
<OTHER-EXPENSES>                              (20,137)
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                           2,939,157
<INCOME-PRETAX>                            (2,594,626)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (2,594,626)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (2,594,626)
<EPS-PRIMARY>                                   (9.83)
<EPS-DILUTED>                                   (9.83)
        

</TABLE>
#### Griffith Oil Company, Inc., et al., Respondents, v National Union Fire Insurance Company of Pittsburgh, Pa., Appellant, et al., Defendants.

Submitted September 13, 2010;

decided September 16, 2010

*829Motion by United Policyholders et al. for leave to file a brief amici curiae on the appeal herein granted and the proposed brief is accepted as filed. Two copies of the brief must be served and 24 copies filed within seven days.
```

[Congressional Bills 111th Congress]
[From the U.S. Government Publishing Office]
[S. 2811 Introduced in Senate (IS)]

111th CONGRESS
  1st Session
                                S. 2811

  To amend the Migratory Bird Treaty Act to provide for penalties and 
 enforcement for intentionally taking protected avian species, and for 
                            other purposes.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                           November 20, 2009

  Mr. Merkley introduced the following bill; which was read twice and 
       referred to the Committee on Environment and Public Works

_______________________________________________________________________

                                 A BILL

 
  To amend the Migratory Bird Treaty Act to provide for penalties and 
 enforcement for intentionally taking protected avian species, and for 
                            other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Migratory Bird Treaty Act Penalty 
and Enforcement Act of 2009''.

SEC. 2. AMENDMENT OF MIGRATORY BIRD TREATY ACT.

    Section 6 of the Migratory Bird Treaty Act (16 U.S.C. 707) is 
amended by redesignating subsections (c) and (d) as subsections (d) and 
(e), respectively, and by inserting after subsection (b) the following:
    ``(c)(1) Except in the case of hunting and other activity allowed 
under section 3, whoever, in violation of this Act, intentionally and 
maliciously takes by any manner any migratory bird shall be guilty of a 
felony and, upon conviction, shall be fined not more than $50,000 or 
imprisoned for not more than two years, or both, for each violation.
    ``(2) Any person who intentionally and maliciously commits any 
other act or omission in violation of this Act or any regulations 
issued under this Act shall be guilty of a felony and, upon conviction, 
shall be fined not more than $50,000 or imprisoned for not more than 
two years, or both, for each violation.
    ``(3) The Secretary or the Secretary of the Treasury shall pay, 
from sums received as fines under this subsection and subject to the 
availability of appropriations, a reward to any person who furnishes 
information that leads to an arrest or a criminal conviction for any 
violation of this Act. The amount of the reward, if any, shall be 
designated by the Secretary or the Secretary of the Treasury, as 
appropriate. Any officer or employee of the United States or any State 
or local government who furnishes information or renders service in the 
performance of his or her official duties is ineligible for payment 
under this paragraph.''.
                                 <all>
```
##### 



EXHIBIT 32 CERTIFICATION PURSUANT TO
18 U.S.C. § 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002* In connection with the Quarterly Report of IEA Income Fund VIII (the Partnership) on Form
10-Q for the quarterly period ended March 31, 2005, as filed with the Securities and Exchange
Commission (the Report), the undersigned, Dennis J. Tietz, the President and Chief Executive
Officer of Cronos Capital Corp., the General Partner of the Partnership, and John Kallas, the Chief
Financial Officer of Cronos Capital Corp., certify, based on their knowledge, that:  (i)
    The Report fully complies with the requirements of Section 13(a)
or 15(d) of the Securities Exchange Act of 1934; and(ii)
    The information contained in the Report fairly presents, in all
material respects, the financial condition and results of operation of the
Partnership. May 13, 2005 By
    
    /s/ Dennis J. TietzDennis J. Tietz, President and Chief ExecutiveOfficer of Cronos Capital Corp.,General Partner of the Partnership/s/ John KallasJohn Kallas, Chief Financial Officer of CronosCapital Corp., General Partner of the Partnership
 A signed original of this written statement required by Section 906 has been provided to the
Partnership and will be retained by the Partnership and furnished to the Securities and Exchange
Commission or its staff upon request.   *
    
    This certification, required by Section 906 of the Sarbanes-Oxley Act of 2002, other than as
required by Section 906, shall not be deemed to be filed with the Commission or subject to
the rules and regulations promulgated by the Commission under the Securities Exchange Act of
1934, as amended, or to the liabilities of Section 18 of said Act.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Homeland Security

###### Federal Emergency Management Agency

          - [Internal Agency Docket No. FEMA-1858-DR; Docket ID FEMA-2008-0018]

# AGENCY:

Federal Emergency Management Agency, DHS.

# ACTION:

Notice.

# SUMMARY:

This notice amends the notice of a major disaster declaration for the State of Georgia (FEMA-1858-DR), dated September 24, 2009, and related determinations.

# DATES:

*Effective Date:*                         October 8, 2009.                    

# FOR FURTHER INFORMATION CONTACT:

Peggy Miller, Disaster Assistance Directorate, Federal Emergency Management Agency, 500 C Street, SW., Washington, DC 20472, (202) 646-3886.

# SUPPLEMENTARY INFORMATION:

Notice is hereby given that the incident period for this disaster is closed effective October 8, 2009. 

(The following Catalog of Federal Domestic Assistance Numbers (CFDA) are to be used for reporting and drawing funds: 97.030, Community Disaster Loans; 97.031, Cora Brown Fund; 97.032, Crisis Counseling; 97.033, Disaster Legal Services; 97.034, Disaster Unemployment Assistance (DUA); 97.046, Fire Management Assistance Grant; 97.048, Disaster Housing Assistance to Individuals and Households In Presidentially Declared Disaster Areas; 97.049, Presidentially Declared Disaster Assistance—Disaster Housing Operations for Individuals and Households; 97.050, Presidentially Declared Disaster Assistance to Individuals and Households—Other Needs; 97.036, Disaster Grants—Public Assistance (Presidentially Declared Disasters); 97.039, Hazard Mitigation Grant.)

W. Craig Fugate,

Administrator, Federal Emergency Management Agency.

[FR Doc. E9-25388 Filed 10-21-09; 8:45 am]

BILLING CODE 9111-23-P
NIDDK Director for Clinical Obesity Prevention and Treatment Program

The National Institute of Diabetes and Digestive and Kidney diseases (NIDDK) is seeking a 

physician-scientist with experience in clinical obesity research for a program that will 

encompass interventions to prevent and treat obesity ranging from behavioral, 

pharmacological, device, and surgical interventions in adults, to community-based and multisectoral studies in populations experiencing health disparities. The position is in NIDDK’s 

extramural Division of Digestive Diseases and Nutrition. The mission of the division is to support 

research programs in the alimentary GI tract, hepatobiliary system, exocrine pancreas, obesity, 

and nutrition. In fiscal year 2022 the division made approximately 1,429 awards totaling 

approximately $640 million. The Program Director will also work closely with NIDDK’s Office of 

Obesity Research. NIDDK is considered the lead NIH Institute for obesity research, and NIDDK 

Obesity Research funding in fiscal year 2022 was $480 million. In addition to leading and 

managing a program of grants and cooperative agreements, the position includes senior 

advisory and collaborative activities such as planning workshops and initiatives and providing 

scientific expertise to multiple other programs in NIDDK and NIH. 

This position requires an M.D. or equivalent degree with specialization in Internal Medicine 

or Family Medicine and subspecialty training in an area relevant to this program, such as

Endocrinology, Obesity Medicine, Gastroenterology, or Nutrition. The position requires 

training and experience in clinical research in obesity and nutrition in adults. U.S. Citizenship 

is required.

To Apply: In the near future listed global announcements for physicians will be open Monday, 

October 30th and links will be available to USAJobs. 

For more information on the position, contact: Dr. Stephen James: jamess@extra.niddk.nih.gov 

OR Dr. Sue Yanovski: yanovskis@mail.nih.gov. 

The U.S. Department of Health and Human Services (HHS), NIH, and NIDDK are equal 

opportunity employers committed to equity, diversity, and inclusion. 

If you are not currently looking for a new position, please circulate this announcement to 

individuals who might be interested.
# **EXHIBIT 32.1**

 

CERTIFICATION OF CHIEF EXECUTIVE OFFICERPURSUANT TOSECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report on Form 10-Q for the fiscalquarter ended June 30, 2004 (the “Report”) by Bentley Pharmaceuticals, Inc.(the “Registrant”), the undersigned hereby certifies that, to his knowledge:

 

1.               The Report fully complies with therequirements of section 13(a) or 15(d) of the Securities Exchange Act of1934, as amended, and

 

2.               The information contained in the Reportfairly presents, in all material respects, the financial condition and resultsof operations of the Registrant.

 

 
|   | /s/ James R. Murphy                                                        |   |
|--------|----------------------------------------------------------------------------|--------|
|   | James R. Murphy                                                            |
|   | Chairman of the Board of Directors,  President and Chief Executive Officer |
|   | (Principal Executive Officer)                                              |
|   |                                                                       |
|   | August 4, 2004                                                        |

 

----
Exhibit 99.1

Certification of Chief Executive Officer, Chief Financial Officer and Principal Accounting Officer pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350)

Pursuant
to 18 U.S.C. §1350, each of the undersigned certifies that this Quarterly Report on Form 10-QSB for the period ended June 30, 2002 fully
complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that the information contained in this report fairly presents, in all material respects, the
financial condition and results of operations of Bio-Imaging Technologies, Inc.

|DATE: August 7, 2002 |  | By: |  | /s/MARK L. WEINSTEINMark L. Weinstein, President,
Chief Executive Officer and
Chief Financial Officer
(Principal Executive Officer
and Principal Financial Officer)
|-------------------- |  | --- |  | -------------------------------------------------------------------------------------------------------------------------------------------------------------------
|DATE: August 7, 2002 |  | By: |  | /s/MARIA T. KRAUSMaria T. Kraus, Controller
(Principal Accounting Officer)                                                                                         

---

QuickLinks
<PAGE>

                                                                    EXHIBIT 31.1

                                  CERTIFICATION

I, Emile Loria, certify that:

1.    I have reviewed this quarterly report on Form 10-Q of Epimmune Inc.;

2.    Based on my knowledge, this report does not contain any untrue statement
of a material fact or omit to state a material fact necessary to make the
statements made, in light of the circumstances under which such statements were
made, not misleading with respect to the period covered by this report;

3.    Based on my knowledge, the financial statements, and other financial
information included in this report, fairly present in all material respects the
financial condition, results of operations and cash flows of the registrant as
of, and for, the periods presented in this report;

4.    The registrant's other certifying officer and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

      a) designed such disclosure controls and procedures, or caused such
disclosure controls and procedures to be designed under our supervision, to
ensure that material information relating to the registrant, including its
consolidated subsidiaries, is made known to us by others within those entities,
particularly during the period in which this report is being prepared;

      b) evaluated the effectiveness of the registrant's disclosure controls and
procedures and presented in this report our conclusions about the effectiveness
of the disclosure controls and procedures, as of the end of the period covered
by this report based on such evaluation; and

      c) disclosed in this report any change in the registrant's internal
control over financial reporting that occurred during the registrant's most
recent fiscal quarter that has materially affected or is reasonably likely to
materially affect, the registrant's internal control over financial reporting;
and

5.    The registrant's other certifying officer and I have disclosed, based on
our most recent evaluation of internal control over financial reporting, to the
registrant's auditors and the audit committee of registrant's board of directors
(or persons performing the equivalent functions):

      a) all significant deficiencies and material weaknesses in the design or
operation of internal control over financial reporting which are reasonably
likely to adversely affect the registrant's ability to record, process,
summarize and report financial information; and

      b) any fraud, whether or not material, that involves management or other
employees who have a significant role in the registrant's internal control over
financial reporting.

Dated: August 11, 2004

                                         /s/ Emile Loria
                                         ---------------------------------------
                                         Dr. Emile Loria
                                         President and Chief Executive Officer

                                        1
UN PUBLISHED
UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT

No. 21

- 7651

JERRELL ANTONIO ROBERTS , Petitioner

- Appellant ,

v.
BRYAN DOBBS , Respondent

- Appellee

.

Appeal from the United States District Court for the District of South Carolina , at Beaufort

. Joseph Dawson, III , District Judge. ( 9:21

- cv - 00004

- JD )

Submitted : July 21, 2022 Decided: July 25, 2022

Before MOTZ, HARRIS, and RUSHING , Circuit Judges.

Affirmed by un published per curiam opinion

.
Jerrell Antonio Roberts, Appellant Pro Se.

Unpublished opinions are not binding precedent in this circuit. USCA4 Appeal: 21-7651 Doc: 13 Filed: 07/25/2022 Pg: 1 of 32 PER CURIAM: Jerrell Antonio Roberts, a federal prisoner, appeals the district court’s order accepting the magistrate judge’s recommendation and dismissing without prejudice for lack of jurisdiction Roberts’ 28 U.S.C. § 2241 petition in which Roberts sought to challenge his 18 U.S.C. § 922(g) conviction by way of the savings clause i n 28 U.S.C. § 2255. Pursuant to § 2255(e), a prisoner may challenge his conviction in a traditional writ of habeas corpus pursuant to § 2241 if a § 2255 motion would be inadequate or ineffective to test the legality of his detention. [Section] 2255 is ina dequate and ineffective to test the legality of a conviction when: (1) at the time of conviction, settled law of this circuit or the Supreme Court established the legality of the conviction; (2) subsequent to the prisoner ’ s direct appeal and first § 2255 motion, the substantive law changed such that the conduct of which the prisoner was convicted is deemed not to be criminal; and (3) the prisoner cannot satisfy the gatekeeping provisions of § 2255 because the new rule is not one of constitutional law.
In r e Jones , 226 F.3d 328, 333

- 34 (4th Cir. 2000). We have reviewed the record and, given Roberts’ concession that he has not yet filed a § 2255 motion relevant to the challenged conviction, we find no reversible error in
the district court’s conclusion that i t lacked jurisdiction to consider Roberts’ § 2241 petition. See Marlowe v. Warden, FCI Hazelton , 6 F.4th 562, 568

- 69 (4th Cir. 2021) (reiterating that “[t]he Section 2255 remedy is not rendered inadequate or ineffective merely because an individual has be en unable to obtain relief under that provision, or because an individual is procedurally barred from filing a Section 2255 motion” (cleaned up) )

. Accordingly, we affirm the district court’s order. We dispense with oral argument USCA4 Appeal: 21-7651 Doc: 13 Filed: 07/25/2022 Pg: 2 of 33 because the facts and leg al contentions are adequately presented in the materials before this court and argument would not aid the decisional process.

AFFIRMED USCA4 Appeal: 21-7651 Doc: 13 Filed: 07/25/2022 Pg: 3 of 3